Casie E. Horgan, MPH

Senior Research Analyst/Epidemiologist
Department of Population Medicine, Harvard Pilgrim Health Care Institute

Poster(s):

• (067) Risk of Incident Inflammatory Bowel Disease in New Users of Dipeptidyl Peptidase 4 Inhibitors and Sodium Glucose Cotransporter 2 Inhibitors in the FDA Sentinel System
  Tuesday, August 27, 2024

  8:00 AM – 6:00 PM CEST

• (332) Background Rates of Neuroinflammatory Disorders and Atrial Fibrillation – Conditions of Interest for Vaccine Safety Studies
  Wednesday, August 28, 2024

  8:00 AM – 1:30 PM CEST